
|Videos|November 16, 2022
Captisol- Why it’s the UNRIVALED Modified Cyclodextrin
Author(s)Ligand
Key Learning Objectives
- Captisol is in over a dozen FDA approved products with multiple product approvals coming in the next year. These approvals include oral and ophthalmic routes of administration. Proven safe!
- A team of experts with 20+ years of experience who are ready to answer any questions are what sets Captisol apart from other modified cyclodextrins.
- Ligand formulation services are now available to assist with consideration of CAPTISOL for solving product development issues and achieving Target Product Profile goals
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer
4
Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies
5




